Metastatic Malignant Neoplasm in the Bone clinical trials
9 active trials name this condition. Describe your situation to see which ones look like a fit.
By location
- Simulation-Free, Single-Fraction Palliative Radiation Therapy for Treatment of Bone Metastases
- A Phase III Randomized Trial Comparing Stereotactic Body Radiation Therapy (SBRT) vs Conventional Palliative Radiation Therapy for Painful Bone Metastases
- Post-Op Pain Control for Prophylactic Intramedullary Nailing.
- Registry for Bone Metastases
- A Multi-Center Observational Trial of Symptomatic, High-Risk Bone Metastases Treated With Percutaneous Ablation and Palliative Radiation Therapy
- Abductor Reattachment Methods in Proximal Femur Replacements: What is the Best Method?
- Samarium Optimized for Long-lasting Analgesia in Cancerous End-stage Bone Pain
- Intraoperative Neuromonitoring of Sacral Reflexes to Predict Post Operative Function in Patients Undergoing Sacrectomy for Pelvic Bone Malignancy or Patients Undergoing Spinal Procedures Without Sacral Root Involvement
- LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Metastatic Malignant Neoplasm in the Bone” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.